CClinicalTrials.gg
Status unknownNCT04910672Updated Jun 2, 2021

Primary Dysmenorrhea and Osteopathic Treatment

An interventional study of Control Group and Experimental Group in Pelvic Pain, Pelvic Pain Syndrome and Sexual Dysfunction, sponsored by Escuela de osteopatía de Madrid. Status unknown at 1 site in Spain. Open to female participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-02.

Sponsored by Escuela de osteopatía de Madrid · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

This study is adressed to women with primary dysmenorrhea, it´s a gynecological disorder that is defined as colicky pain associated with menstruation and is located in the lower abdomen and in the lumbo-pelvic area. It appears between the first 8-72 hours and four days of the menstrual cycle and affects almost 85% of women, 30% of them severely. This study aims to demonstrate that osteopathic manual therapy is an effective therapeutic option in patients with primary dysmenorrhea. Another objective is to verify that osteopathic manual treatment provides an improvement in the intensity of pain, quality of life and a reduction in the consumption of medicines in these patients.

Read the detailed description

It will be a prospective study, a double-blind randomized controlled clinical trial. The sample group will include 60 patients, between 18 and 30 years old divided into two experimental groups. The experimental group (n = 30) will be treated following an osteopathic treatment, through a bilateral global pelvic manupulation (GPM) and a specific internal technique for mobility of the cervix, and the control group (n = 30) will only carry out a bilateral GPM. A measurement will be made before the first treatment, another after each session, and the last one two weeks after the last intervention (anthropometric measurements, quality of life questionnaire, sexual health, osteopathic tests, pressure point with algometer, pain and medicines consumption). The established outcome measures are: pain intensity according to the visual analog scale (VAS), depression points measured with an algometer, a health-related quality of life questionnaire, questionnaire sexual health and sexual dysfunctions, and the measurement of drug consumption.

02

Conditions studied

  • Pelvic Pain
  • Pelvic Pain Syndrome
  • Sexual Dysfunction

Keywords

  • Primary Dysmenorrhea
  • Spinal Manipulation
  • Pelvic Pain
  • Pain Threshold
  • Sexual Dysfunctions
  • Osteopathic Treatment
  • Manual therapy
  • Visceral Manipulation
03

In context

Pelvic Pain

375 studies on the registry are indexed under Pelvic Pain; 83 are open to participants now.

This study's planned enrollment of 60 is above the median of 54 across 273 interventional studies indexed under Pelvic Pain.

Browse Pelvic Pain studies →

Lead sponsor

This is the only study on the registry with Escuela de osteopatía de Madrid as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Crampy pain in the lower abdomen or lumbo-pelvic area between 8 hours and 4 days after menstrual bleeding.
  • Clinical evolution of at least three menstrual cycles with said pathology.
  • Moderate menstrual pain or severe intensity, minimum 5 VAS scale.
  • Regular menstrual cycle, between 21 and 35 days.
  • Accept informed consent.

Exclusion criteria

Exclusion Criteria:

  • Being receiving any other physiotherapeutic or pharmacological treatment for primary dysmenorrhea during the 3 weeks prior to the beginning of the intervention.
  • Suffering from cardiovascular diseases, prolapse, amenorrhea, hemophilia, tumor or infectious processes, use of IUDs, consumption of oral contraceptives or suffering from any injury that affects the sensory-motor function.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Control Group

    The control group (n = 30) will only carry out a bilateral global pelvic manipulation

    Other: Control Group

  • Experimental
    Experimental Group

    The experimental group (n = 30) will be treated following an osteopathic treatment, through a bilateral global pelvic manipulation and a specific internal technique for mobility of the cervix

    Other: Experimental Group

Interventions

  • OtherControl Group

    Bilateral global pelvic manipulation. Lower right limb in extension. The left lower limb in flexion, until the tension on the SPIS was felt. Introduce very little rotation of the spine. ASI anterior slide until crease forms at waist. We bring the elbow towards our hips. We rotate the patient posteriorly to open the lumbo sacral facet. The thrust is performed by simultaneously increasing these three parameters, with kick and joint compression.

  • OtherExperimental Group

    Bilateral Global Pelvic Manipulation and Internal Correction Technique for Laterflexion of the Uterus The technique consists of making contact with the vaginal fingers on the upper and anterior part of the cervix, while the abdominal hand, dragging the skin towards the pubis, tries to make contact as posterior as possible on the fundus of the uterus. The technique consists, while the patient breathes widely, in progressively raising the uterine fundus forward and upward and lowering the cervix until the normal anteversion position is achieved. At the end of the technique, fixing the correction position of the uterus, we can ask the patient to perform a pelvic anteversion, while the correction is maintained. At the end of the technique, all abnormal tension should have disappeared and the uterus should have recovered a physiological position of anteversion.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in the Visual Analogue Scale (pain) during menstruation at week 4, 8 and 10.

    Measured before the treatment in each meeting, asking about the pain during the last menstrual period. The higher is the value of the scale, the worse.

    Time frame: Baseline and week 4, 8 and 10

  2. Change from Baseline in the Specific Quality of Life Questionnaire Related to Menstruation CVM-22 at weeks 4, 8 and 10

    The CVM-22, self-administered Likert type, is made up of 22 items. The questionnaire score ranges from 0 to 66, where the higher the score the worse the CVM-22.

    Time frame: Baseline and weeks 4, 8 and 10

  3. Change from Baseline in the Questionnaire on sexual health and detection of female sexual dysfunctions in primary care (SyDSF-AP) at weeks 4, 8 and 10

    Self-administered questionnaire of 20 closed questions, although 8, 9 and 19 have an open component, and 1 is an open question, which is integrated into domains. Those of the descriptive sociodemographic domain and the health condition help to know the profile of the surveyed women, as well as the factors that may influence their sexuality. The domain of sexual function ranges from question 10 to 18 and is answered using a Likert scale of 5 values. In addition, question 20 has been included to assess satisfaction with your partner from 0 to 10. Finally, question 21 is open to collect the comments that may arise during the completion of the questionnaire.

    Time frame: Baseline and weeks 4, 8 and 10

  4. change from baseline in the values of the pressure algometer measured on 9 different points at weeks 4, 8 and 10.

    The Pressure Threshold is defined as the minimum pressure that triggers a painful response. The WAGNER brand "FORCE TEN" pressure algometer was used to quantify the Pressure Thereshold at the 9 sensitive pressure points of dysmenorrhea. The rubber tip was used to focus the pressure exerted by the evaluator and it was placed perpendicular to each point. The measurements were carried out 3 times for each point (with 10 seconds of difference between each measurement, 30 before moving on to another point) and calculating the mean value. Before carrying out the measurements, the patients were instructed in the procedure, giving as an example an area not included in the assessment. When the pressure sensation started to be painful, they should tell the evaluator.

    Time frame: Pre-intervention and post-intervention in Baseline and weeks 4 and 8. Another measure without intervention in week 10.

  5. Change from baseline in Medication intake during the menstrual period at weeks 4, 8 and 10.

    The average consumption of NSAIDs by the dose of medication used, self-reported responses by the participants. It will be recorded in a journal that will be given to them to write down.

    Time frame: Baseline and weeks 4, 8 and 10

07

Study locations

1 site
  • Miriam Corona Lozano
    Arcos de la Frontera, Cádiz 11630, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04910672
Lead sponsor
Escuela de osteopatía de Madrid
Collaborators
University of Seville
Responsible party
Sara Santiago Tello (physiotherapist, Escuela de osteopatía de Madrid) — Principal investigator
First posted
Jun 2, 2021
Start date
Jul 2021 (estimated)
Primary completion
Sep 2021 (estimated)
Completion
Nov 2021 (estimated)
Last update
Jun 2, 2021

Study contacts

Sara S Tello, PT
Contact
sara_santiago_tello@hotmail.com
651458007
Miriam C Lozano, PT
Contact
myriam.corona.lozano@gmail.com
677540058
François Ricard, DO
study director · Escuela Osteopatía Madrid

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion